RenovoRx, Inc.
RNXT
$0.9403
$0.04695.25%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 2.01% | 28.88% | 9.68% | -13.00% | 2.90% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.18% | 33.56% | 50.53% | -5.20% | -10.10% |
Operating Income | 11.73% | -25.61% | -48.11% | 5.20% | 10.10% |
Income Before Tax | -21.18% | -124.91% | 10.81% | -73.89% | -2.66% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -21.18% | -124.91% | 10.81% | -73.89% | -2.66% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -21.18% | -124.91% | 10.81% | -73.89% | -2.66% |
EBIT | 11.73% | -25.61% | -48.11% | 5.20% | 10.10% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 20.34% | -7.08% | 62.00% | 25.43% | 54.53% |
Normalized Basic EPS | 20.29% | -7.11% | 62.02% | 25.51% | 54.51% |
EPS Diluted | 20.34% | -7.08% | 62.00% | 25.43% | 54.53% |
Normalized Diluted EPS | 20.29% | -7.11% | 62.02% | 25.51% | 54.51% |
Average Basic Shares Outstanding | 52.09% | 110.04% | 134.70% | 133.24% | 125.70% |
Average Diluted Shares Outstanding | 52.09% | 110.04% | 134.70% | 133.24% | 125.70% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |